Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teaching at the Convergence of Pandemics and Historically Excluded Patient Populations: The Challenges, and Importance, of Culturally Responsive Communication.

Teaching and learning in medicine·2023
Same author

A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement.

Harm reduction journal·2022
Same author

A Comparative Analysis of Online Versus in-Person Opioid Overdose Awareness and Reversal Training for First-Year Medical Students.

Substance use & misuse·2021
Same author

Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study.

Journal of acquired immune deficiency syndromes (1999)·2020
Same author

Impact and Reception of a Required 4-Week Palliative Medicine Rotation.

Family medicine·2018
Same author

End-of-life care in advanced dementia.

Postgraduate medicine·2014

Related Experiment Video

Updated: May 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Transient ischemic attack: Part II. Risk factor modification and treatment.

B Brent Simmons1, Annette B Gadegbeku, Barbara Cirignano

  • 1Drexel University College of Medicine, Philadelphia, PA 19127, USA. bsimmons@drexelmed.edu

American Family Physician
|October 16, 2012
PubMed
Summary

Preventing future strokes after a transient ischemic attack (TIA) involves managing risk factors like hypertension and diabetes. Early hospital admission and treatments such as antiplatelet agents and statins are recommended for stroke risk reduction.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Experiment Videos

Last Updated: May 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

  • Neurology
  • Cardiology
  • Preventive Medicine

Background:

  • Transient ischemic attack (TIA) is a critical warning sign for future stroke.
  • Modifiable risk factors including hypertension, smoking, obesity, and dyslipidemia significantly increase TIA and stroke risk.
  • Hospital admission within 48 hours of TIA symptom resolution facilitates prompt evaluation and intervention.

Purpose of the Study:

  • To outline evidence-based interventions for preventing recurrent ischemic events after a transient ischemic attack.
  • To detail recommended pharmacological and procedural strategies for long-term stroke prevention.
  • To emphasize the importance of risk factor modification in TIA management.

Main Methods:

  • Review of American Heart Association/American Stroke Association guidelines for TIA management.
  • Analysis of evidence supporting antiplatelet agents, statins, and carotid artery intervention.
  • Evaluation of risk factor control strategies for reducing TIA and stroke incidence.

Main Results:

  • Controlling hypertension, smoking, obesity, diabetes, and dyslipidemia dramatically reduces stroke risk.
  • Antiplatelet agents (aspirin, aspirin/extended-release dipyridamole, clopidogrel) are recommended first-line therapies.
  • Statins reduce stroke risk post-TIA, with optimal benefit seen at LDL cholesterol reduction ≥50% or <70 mg/dL.
  • Carotid endarterectomy is advised for 70-99% stenosis if perioperative risk is <6%.

Conclusions:

  • Comprehensive management of modifiable risk factors is crucial for preventing stroke after TIA.
  • Pharmacological interventions, including antiplatelet therapy and statins, are key components of secondary stroke prevention.
  • Carotid revascularization should be considered for severe stenosis in appropriate patients to mitigate stroke risk.